PROCTER & GAMBLE HEALTH
|
The Current P/S Ratio of PROCTER & GAMBLE HEALTH is 6.34.
Share Price | ₹4,720.7 | Apr 25,2024 |
Market Cap | ₹7,836.4 Cr | |
Sales-TTM | ₹1,237.0 Cr | TTM-Standalone Results |
Price/Sales | 6.34x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of PROCTER & GAMBLE HEALTH
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹7,836.4 Cr] as on Apr 25,2024
(/) Sales [ ₹1,237.0 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 6.34x ]
Thus, for PROCTER & GAMBLE HEALTH , the investors are currently willing to pay '6.34 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of PROCTER & GAMBLE HEALTH !
The chart below summarizes the trend in P/S Ratio of PROCTER & GAMBLE HEALTH over the last five years.
Historical PS (Price/Sales) ratio chart of PROCTER & GAMBLE HEALTH
PS Ratio Performance Analysis for PROCTER & GAMBLE HEALTH
- PROCTER & GAMBLE HEALTH 's p/e ratio for fiscal years ending Jun2023 to Dec2018 averaged 6.71x.
- PROCTER & GAMBLE HEALTH 's operated at median p/e ratio of 6.24x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PROCTER & GAMBLE HEALTH 's p/e ratio peaked in Jun2021 at 9.21x.
- PROCTER & GAMBLE HEALTH 's p/e ratio hit its five-year low in Jun2020 of 4.98x.
How does PROCTER & GAMBLE HEALTH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
PROCTER & GAMBLE HEALTH | 1,237.0 | 6.34 | 7,836.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 47,444.6 | 7.69 | 364,831.0 |
CIPLA LTD | 25,350.2 | 4.48 | 113,471.0 |
DR REDDYS LABORATORIES LTD | 27,212.5 | 3.81 | 103,713.0 |
ZYDUS LIFESCIENCES LTD | 19,024.2 | 5.03 | 95,687.8 |
DIVIS LABORATORIES LTD | 7,492.8 | 13.61 | 101,960.0 |
MANKIND PHARMA LTD | 9,946.3 | 9.66 | 96,093.1 |
TORRENT PHARMACEUTICALS LTD | 10,474.0 | 8.70 | 91,124.7 |
LUPIN LTD | 19,480.1 | 3.73 | 72,687.6 |
AUROBINDO PHARMA LTD | 27,894.7 | 2.32 | 64,661.3 |
ABBOTT INDIA LTD | 5,753.4 | 9.48 | 54,533.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PROCTER & GAMBLE HEALTH 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.32x |
Max industry PS | 13.61x |
Median industry PS | 6.34x |
Average industry PS | 6.80x |
You may also like the below Video Courses